Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Author(s) -
Søren S. Lund,
Lise Tarnow,
M. Frandsen,
U. Smidt,
Oluf Pedersen,
HansHenrik Parving,
Allan Vaag
Publication year - 2008
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-07-0500e
Subject(s) - repaglinide , medicine , postprandial , endocrinology , metformin , type 2 diabetes , post prandial , insulin , secretagogue , diabetes mellitus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom